BabyguardTM is a cell-based non-invasive, prenatal examination technology, simple, safe,comprehensive and rapid, designed specifically for the detection of fetal genetic diseases. Only 10~20 ml  venous blood is needed from a pregnant female to perform the examination that is capable of detecting 3500 fetal genetic diseases.

This technology has not only the advantages of concurrent non-invasive prenatal examinations: non-invasive sampling, no miscarriage risk, early detection at first and second trimester, but also possesses other advantages:

     ● The testing subject is the intact circulating fetal cell (CFC) present in the maternal blood, no longer restricted to the tragmented cell free fetal DNA circulating in the the maternal blood.

    ● The world-leading whole-genome and transcriptome sequencing technologies, which can obtain a full spectrum of genetic information from a single fetal cell.

    ● The technology allows the detection of up to 3500 mutations associated with genetic disorders, not limited to a few chromosomal diseases.

Basetra has the top-tier technologies and patents, aiming to provide the safest, most accurate and latest non-invasive examination service.

Categories of pregnant females suitable for BabayguardTM

    ● High risk woman older than 35 and not willing to be subjected to invasive prenatal examinations, but also suitable for medium risk woman above 30 years of ago at conception.

    ● At early and middle stage of pregnancy with high serological risk and not willing to be subjected to invasive prenatal examination such as amniocentesis or CVS.

    ● Showing increase in NT value or other anatomic abnormalities in the result of fetal B-type ultrasonography and not willing to be subjected to invasive prenatal examination.

    ● Either parent has chromosomal disease, or exposure to malformation-inducible substance, or has history of giving birth to infants with chromosomal diseases and not willing to be subjected to invasive prenatal examination.

    ● Conditions not suitable for invasive prenatal examinations, e.g. virus carriers, placenta dislocation, low implantation of placenta, amniotic fluid inadequacy, negative RH blood, having history of abortion, symptoms of miscarriage or Precious Baby.

    ● Culture of amniocentesis cells failed, not willing or not capable to be subjected to invasive prenatal examination.

    ● Willing to be subjected to non-invasive prenatal examination, hoping to exclude fetal chromosomal diseases.

Suitable Timing for BabyguardTM Examination 

Best timing for examination is between 10 and 26 weeks pregnancy to minimize health risk to pregnant women, 10-12 weeks are recommended.

What disease can be detected by BabyguardTM 

Over 3500 genetic disorders detectable by BabyguardTM, e.g.:

    ● Down Syndrome caused by the disorder of chromosome 21, causing intelligence and physical development delay of the infant, occurrence: 1 in 691.

    ● Polydactyly, induced by mutation of autosome, causing increased number of toes or fingers, occurrence: 1 in 500.

    ● Cleft Palate, genetic factors associated with abnormal facial growth, occurrence: 1 in 250.